| AbbVie AG - Duodopa, Gel zur intestinalen Anwendung |
| 57624 | | 01 | | Duodopa | | Gel zur intestinalen Anwendung | | N04BA02 | | Levodopa and Decarboxylase Inhibitor | | 21.12.2006 | | |
|
| Composition |
| levodopum 2000 mg, carbidopum 463 mg ut carbidopum monohydricum, carmellosum natricum corresp. natrium 277.4 mg, aqua purificata, ad gelatum pro 100 ml. |
| Packungsbestandteile |
| Gel for intestinal application | | | | | Active Agent | Dose |
|---|
| Carbidopa | 463 mg | | Levodopa | 2000 mg |
| | BAG: Active Agent | Dose |
|---|
| Carbidopa | 463 mg | | Levodopa | 2000 mg |
| | | | Inactive agents | Dose |
|---|
| Ad Gelatum | 100 ml | | Aqua Purificata | | | Carmellose Sodium | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 7 Sachet(s) | 405.36 | 457.25 | B | SL | Yes |
|
